Transdermal Cosmetics, the company that makes the first anti-ageing cream to deliver collagen into the skin, is said to have signed a £25 million deal for advertising slots for its launch on US TV this week in exchange for shares. The shares, floated on Plus Markets in early December with a view to moving to AIM, were steady at 6.5p.

A BEAUTY products group that claims to own a revolutionary anti-ageing cream is to float on London's Plus Markets exchange this week with an expected value of about £60milion.